Trials / Unknown
UnknownNCT05336838
Improving Management of Post-partum Haemorrhage With Quantra® System
Use of Quantra® System in Clinical Practice to Improve Management of Post-partum Haemorrhage : a Prospective Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Post partum haemorrhage is a concerning situation in maternity wards, though it is not the first cause of maternal mortality anymore. It has been already shown that low fibrinogen level is a major predictive factor of massive bleeding after delivery. In this situation, the early knowledge of fibrinogen level could enhance care of women experiencing post partum haemorrhage. In a cohort of women suffering from post partum haemorrhage, this study will evaluate whether assessing fibrinogen level would be faster using the Quantra® system than the standard coagulation test.
Conditions
Timeline
- Start date
- 2022-05-01
- Primary completion
- 2023-05-01
- Completion
- 2023-05-01
- First posted
- 2022-04-20
- Last updated
- 2022-04-20
Source: ClinicalTrials.gov record NCT05336838. Inclusion in this directory is not an endorsement.